Feedback / Questions
sabirnetug IV (ACU193 IV) - Acumen Pharma
https://www.globenewswire.com/news-release/2024/04/04/2857726/0/en/Acumen-Pharmaceuticals-Collaborates-with-Lonza-to-Advance-Sabirnetug-for-the-Treatment-of-Alzheimer-s-Disease.html
Apr 4, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next